{"organizations": ["Gilead"], "uuid": "91bc0ee93eafa2df7c0550273e48df460bcdd852", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "news.investors.com", "main_image": "http://www.investors.com/image/IT90-biotech-0720-iStock.jpg.cms", "site_section": "http://finance.yahoo.com/rss/headline?s=NVS", "section_title": "Yahoo! Finance: NVS News", "url": "http://news.investors.com/071815-762183-q2-earnings-preview-of-biib-nvs-bmy-lly-vrx-abbv.htm?ven=yahoocp&src=aurlled&ven=yahoo", "country": "US", "title": "6 Big-Cap Drugmakers Reporting Earnings Next Week", "performance_score": 0, "site": "investors.com", "participants_count": 0, "title_full": "6 Big-Cap Drugmakers Reporting Earnings Next Week", "spam_score": 0.0, "site_type": "news", "published": "2015-07-18T15:02:00.000+03:00", "replies_count": 0, "uuid": "91bc0ee93eafa2df7c0550273e48df460bcdd852"}, "author": "", "url": "http://news.investors.com/071815-762183-q2-earnings-preview-of-biib-nvs-bmy-lly-vrx-abbv.htm?ven=yahoocp&src=aurlled&ven=yahoo", "ord_in_thread": 0, "title": "6 Big-Cap Drugmakers Reporting Earnings Next Week", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Gilead's Fantastic Growth Expected To Slow \nWith nearly 400 companies in IBD's biotech industry group, it takes a lot to stand out, and Gilead Sciences (NASDAQ:GILD) is doing that with its profit growth. The company's three-year average earnings growth rate of 74% is sixth highest, and its 2014 EPS rise was fourth best. To be sure, dozens of ... 07/17/2015 06:48 PM ET Newfound Market Strength Could Benefit These IBD 50 Names \nThe stock market often does what's least expected, and that certainly has been the case lately. Consider these four recent occurrences: A heavy distribution-day count for the Nasdaq and S&P 500 in recent weeks didn't do much damage to the market. In fact, the market uptrend resumed Thursday ... 07/17/2015 06:48 PM ET Which Top Biotechs Still In Play After Celgene Rally? \nThis week's list of leading stocks near buy points includes a healthy dose of medical names, from biotechs to managed care providers. The biotech revival began prior to Celgene's (NASDAQ:CELG) 7% jump Wednesday on its $7.2 billion buy of Receptos (NASDAQ:RCPT). Celgene is extended past a 121.57 ... 07/16/2015 06:45 PM ET 7 Reasons Foreign Stocks May Outperform In 2nd Half \nChaos seems to reign worldwide. Riots entered Greece's debt drama Wednesday. Combat continues in Ukraine. China's stocks are melting. Yet world stock mutual funds outperformed U.S. diversified stock funds, 1.90% to 1.51%, this year through July 9, says Lipper Inc. So should investors expect foreign ... 07/15/2015 06:36 PM ET Fitbit Leads Trio Of Hot Health-Related IPO Stocks \nNew analyst coverage and a big Celgene deal helped give a healthy boost to hot new issue Fitbit (NYSE:FIT) and a pair of recent biotech IPOs Wednesday. Fitbit hit a second straight new high as it continues its hot streak. The June 18 IPO, which ran up 48% its first day to become the biggest tech ... 07/15/2015 05:50 PM ET Microsoft Set For 'Golden Age' Of Cloud Computing \nWith some bad news out of the way, Microsoft (NASDAQ:MSFT) hopes to turn investor attention next week to what's working for the company. On July 8, the Redmond, Wash.-based software leader took a $7.6 billion impairment charge related to its ill-conceived purchase of Nokia's (NYSE:NOK) mobile phone ... 08:02 AM ET Move Aside Apple: 8 IBD 50 Stocks With Earnings Due \nEarnings season is now in high gear, with all eyes on Apple's (NASDAQ:AAPL) report Tuesday. While the iPhone maker should deliver another quarter of solid profit and sales growth, Apple isn't on the IBD 50 list of the very best stocks. In the coming week, eight companies from the elite IBD 50 are ... 08:02 AM ET Can IBM Q2 Earnings Be Saved By Strategic Investment? \nDeep in transition, IBM (NYSE:IBM) will report second-quarter earnings Monday with expectations for its 13th quarter in a row of year-over-year declining revenue. The consensus estimate is that IBM will report revenue of $20.94 billion, down 13% from the year-earlier quarter. Analysts polled by ... 08:02 AM ET What's a fair price for Netflix? Analysts debate \nNetflix (NASDAQ:NFLX) stock notched its second record high in as many days on Friday, before turning south and taking a slight loss for the day. Netflix peaked at 117.88 intraday Friday, passing its previous all-time high of 116.49 from Thursday. But Netflix closed the session at 114.77, down 0.9%. ... 07/17/2015 06:37 PM ET Tesla Model S Gets Ludicrous; Will Price Cut Hit Margin? \nTesla Motors (NASDAQ:TSLA) stock rose 3% on news Friday that a Model S will go from 0-60 miles per hour in just 2.8 seconds â€” what CEO Elon Musk calls Ludicrous Mode, and other announcements, including longer driving range. But one of the announcements ties to something that could lower the ... 07/17/2015 04:20 PM ET", "external_links": [], "published": "2015-07-18T15:02:00.000+03:00", "crawled": "2015-07-18T19:31:09.000+03:00", "highlightTitle": ""}